عنوان

Developing biomarker-based tools for cancer screening, diagnosis, and treatment :

(Number (ISBN

0309658144

(Number (ISBN

1280704926

(Number (ISBN

9780309658140

(Number (ISBN

9781280704925

Number

b600884

Title Proper

Developing biomarker-based tools for cancer screening, diagnosis, and treatment :

General Material Designation

[Book]

Other Title Information

the state of the science, evaluation, implementation, and economics : workshop summary

First Statement of Responsibility

Margie Patlak and Sharyl Nass, rapporteurs; National Cancer Policy Forum.

Place of Publication, Distribution, etc.

Washington, D.C.

Name of Publisher, Distributor, etc.

National Academies Press

Date of Publication, Distribution, etc.

©2006.

Specific Material Designation and Extent of Item

(x, 102 pages) : illustrations

Text of Note

Cover --; Reviewers --; Contents --; Introduction --; Overview of Technologies Used to Discover Cancer Biomarkers --; Genomics, Proteomics, and Metabolomics --; Molecular Imaging --; Meeting the Technical Challenges of Biomarker Validation and Qualification --; Coordinating the Development of Biomarkers and Targeted Therapies --; Therapeutics Industry Perspective --; Diagnostics Industry Perspective --; NCI Perspective --; Clinical Investigator Perspective --; Biomarker Development and Regulatory Oversight --; FDA Critical Path Initiative --; Oversight of Diagnostic Tests --; Designing Clinical Studies of Biomarkers --; Assessment and Adoption of Biomarker-Based Technologies --; Federal Programs for Technology Assessment --; Insurance Coverage Decisions and Practice Guidelines --; CMS Coverage of Biomarkers --; Economic Impact of Biomarkers --; Cost-Effectiveness Analysis --; The Value of Information and Research --; Technology Assessment in the Private Sector --; Clinical Development Strategies for Biomarker Utilization Discussion --; Strategies for Implementing Standardized Biorepositories Discussion --; Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion --; Strategies to Develop Biomarkers for Early Detection Discussion --; Mechanisms for Developing an Evidence Base Discussion --; Evaluation of Evidence in Decision Making Discussion --; Incorporating Biomarker Evidence Into Clinical Practice Discussion --; Acronyms --; Glossary --; References --; Appendixes --; Appendix A Workshop Agenda --; Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants --; Last Page.

Mass Screening -- methods -- Congresses.

Neoplasms -- prevention and control -- Congresses.

Tumor markers -- Congresses.

Class number

Book number

Margie Patlak and Sharyl Nass, rapporteurs; National Cancer Policy Forum.

Margie Patlak

National Cancer Policy Forum (U.S.)

Sharyl J Nass

United States. Department of Health and Human Services.

Electronic name

[Book]

Y